CAND.PHARM. POVL M. ASSENS FOND
CVR number: 14536604
Naverland 22, 2600 Glostrup
Income statement (mDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 252.81 | 273.01 | 2 595.57 | 293.43 | 285.71 |
| Costs of manufacturing | - 231.81 | - 255.08 | - 242.30 | ||
| Gross profit | 252.81 | 273.01 | 27.75 | 38.36 | 43.41 |
| Costs of management | -16.78 | -18.53 | -21.55 | ||
| Costs of distribution | -12.22 | -15.19 | -15.73 | ||
| EBIT | 1.43 | 1.71 | -1.25 | 4.64 | 6.13 |
| Other financial income | 9.91 | 2.46 | 7.02 | ||
| Other financial expenses | -1.37 | -10.52 | -2.38 | ||
| Pre-tax profit | 4.92 | 0.14 | 7.29 | -3.41 | 10.76 |
| Income taxes | -0.05 | 0.76 | -2.35 | ||
| Net earnings | 4.92 | 0.14 | 7.23 | -2.66 | 8.41 |
Assets (mDKK)
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Intangible assets total | |||
| Machinery and equipment | 0.94 | 0.61 | 0.34 |
| Tangible assets total | 0.94 | 0.61 | 0.34 |
| Other receivables | 1.46 | 1.57 | 1.66 |
| Investments total | 1.46 | 1.57 | 1.66 |
| Non-current loans receivable | 81.62 | 70.75 | 70.97 |
| Long term receivables total | 81.62 | 70.75 | 70.97 |
| Finished products/goods | 27.03 | 20.80 | 13.68 |
| Inventories total | 27.03 | 20.80 | 13.68 |
| Current trade debtors | 62.10 | 61.13 | 62.12 |
| Prepayments and accrued income | 0.23 | 0.31 | 0.30 |
| Current other receivables | 0.35 | 6.20 | 1.46 |
| Current deferred tax assets | 0.17 | 2.13 | 0.64 |
| Short term receivables total | 62.85 | 69.76 | 64.53 |
| Cash and bank deposits | 0.56 | 21.31 | 45.75 |
| Cash and cash equivalents | 0.56 | 21.31 | 45.75 |
| Balance sheet total (assets) | 174.46 | 184.80 | 196.93 |
Equity and liabilities (mDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 4.61 | 4.61 | 4.61 | ||
| Shares repurchased | 8.47 | 7.40 | 5.70 | ||
| Other reserves | 2.57 | 0.00 | |||
| Other restricted equity | 6.71 | ||||
| Retained earnings | -4.92 | -0.14 | 76.48 | 92.32 | 88.40 |
| Profit of the financial year | 4.92 | 0.14 | 7.23 | -2.66 | 8.41 |
| Minority interest (BS) | 6.99 | 7.66 | 10.68 | ||
| Shareholders equity total | 113.06 | 109.33 | 117.80 | ||
| Provisions | 0.00 | -0.00 | |||
| Non-current liabilities total | |||||
| Short-term capital loans | 3.63 | ||||
| Current loans from credit institutions | 1.71 | ||||
| Current trade creditors | 52.80 | 70.27 | 72.38 | ||
| Short-term deferred tax liabilities | 0.32 | ||||
| Other non-interest bearing current liabilities | 3.26 | 5.20 | 6.43 | ||
| Current liabilities total | 61.40 | 75.47 | 79.13 | ||
| Balance sheet total (liabilities) | 174.46 | 184.80 | 196.93 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.